tiprankstipranks
Caribou Biosciences (CRBU)
NASDAQ:CRBU
US Market

Caribou Biosciences (CRBU) Financial Statements

Compare
715 Followers

Caribou Biosciences Financial Overview

Caribou Biosciences's market cap is currently $96.72M. The company's EPS TTM is $-1.651; its P/E ratio is ―; Caribou Biosciences is scheduled to report earnings on March 24, 2025, and the estimated EPS forecast is $-0.45. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 9.99M$ 34.48M$ 13.85M$ 9.60M$ 12.36M
Gross Profit$ 9.99M$ -77.60M$ 10.21M$ 8.61M$ -22.06M
Operating Income$ -166.62M$ -116.06M$ -106.40M$ -66.98M$ -36.12M
EBITDA$ -166.62M$ -112.53M$ -104.78M$ -66.00M$ -35.21M
Net Income$ -149.10M$ -102.07M$ -99.42M$ -66.92M$ -34.31M
Balance Sheet
Cash & Short-Term Investments$ 209.54M$ 328.83M$ 317.04M$ 413.51M$ 15.95M
Total Assets$ 313.31M$ 432.21M$ 373.76M$ 442.36M$ 36.05M
Total Debt$ 26.49M$ 27.11M$ 27.75M$ 259.00K$ 1.58M
Net Debt$ 10.19M$ -24.05M$ -30.59M$ -240.16M$ -14.38M
Total Liabilities$ 60.36M$ 63.81M$ 72.89M$ 54.53M$ 59.48M
Stockholders' Equity$ 252.95M$ 368.40M$ 300.87M$ 387.82M$ -23.44M
Cash Flow
Free Cash Flow$ -143.08M$ -104.90M$ -98.02M$ -35.64M$ -34.53M
Operating Cash Flow$ -138.20M$ -93.29M$ -90.97M$ -32.52M$ -33.22M
Investing Cash Flow$ 86.61M$ -68.18M$ -93.25M$ -176.40M$ 6.36M
Financing Cash Flow$ 16.72M$ 154.30M$ 2.13M$ 433.43M$ 1.74M
Currency in USD

Caribou Biosciences Earnings and Revenue History

Caribou Biosciences Debt to Assets

Caribou Biosciences Cash Flow

Caribou Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis